Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population

Journal of the American College of Cardiology

Volumn 67, Issue 18, 2016, Pages 2118-2130

  Rana, Jamal S ^a,b,c   Tabada, Grace H ^b   Solomon, Matthew D ^a,b,d   Lo, Joan C ^a,b,c   Jaffe, Marc G ^a,c   Sung, Sue Hee ^b   Ballantyne, Christie M ^e   Go, Alan S ^b,c,d,f  

^a KAISER PERMANENTE   (United States)

^b DIVISION OF RESEARCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cardiovascular; diabetes mellitus; prediction; race ethnicity; risk factor

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ALGORITHM; ARTICLE; CALIBRATION; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DEATH CERTIFICATE; DIABETES MELLITUS; ELECTRONIC MEDICAL RECORD; ETHNICITY; FEMALE; HEALTH CARE DELIVERY; HISPANIC; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY PREVENTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; ANCESTRY GROUP; BLOOD; CALIFORNIA; CORONARY ARTERY DISEASE; CORONARY DISEASE; ETHNOLOGY; FOLLOW UP; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK ASSESSMENT; STROKE;

ADULT; AGED; CALIFORNIA; CHOLESTEROL, LDL; CONTINENTAL POPULATION GROUPS; CORONARY ARTERY DISEASE; CORONARY DISEASE; DIABETES MELLITUS; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MIDDLE AGED; MYOCARDIAL INFARCTION; PRIMARY PREVENTION; RISK ASSESSMENT; STROKE;

EID: 84966539919     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.02.055     Document Type: Article

References (28)

1. D.C. Goff Jr., D.M. Lloyd-Jones, G. Bennett, and et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 2014 2935 2959
2. N.J. Stone, J.G. Robinson, A.H. Lichtenstein, and et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 2014 2889 2934
3. P.M. Ridker, and N.R. Cook Statins: new American guidelines for prevention of cardiovascular disease Lancet 382 2013 1762 1765
4. A.P. DeFilippis, R. Young, C.J. Carrubba, and et al. An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort Ann Intern Med 162 2015 266 275
5. C. Andersson, D. Enserro, M.G. Larson, and et al. Implications of the US cholesterol guidelines on eligibility for statin therapy in the community: comparison of observed and predicted risks in the Framingham Heart Study Offspring Cohort J Am Heart Assoc 4 2015 e001888
6. D.M. Lloyd-Jones, D. Goff, and N.J. Stone Statins, risk assessment, and the new American prevention guidelines Lancet 383 2014 600 602
7. A. Pursnani, J.M. Massaro, R.B. D'Agostino Sr., and et al. Guideline-based statin eligibility, coronary artery calcification, and cardiovascular events JAMA 314 2015 134 141
8. P. Muntner, L.D. Colantonio, M. Cushman, and et al. Validation of the atherosclerotic cardiovascular disease pooled cohort risk equations JAMA 311 2014 1406 1415
9. M.A. Hlatky, R.M. Ray, D.R. Burwen, and et al. Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative Circ Cardiovasc Qual Outcomes 7 2014 157 162
10. S.C. Smith Jr., and S.M. Grundy 2013 ACC/AHA guideline recommends fixed-dose strategies instead of targeted goals to lower blood cholesterol J Am Coll Cardiol 64 2014 601 612
11. N.R. Cook, and P.M. Ridker Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women's Health Study JAMA Intern Med 174 2014 1964 1971
12. S.E. Nissen Prevention guidelines: bad process, bad outcome JAMA Intern Med 174 2014 1972 1973
13. M.J. Pencina, A.M. Navar-Boggan, R.B. D'Agostino Sr., and et al. Application of new cholesterol guidelines to a population-based sample N Engl J Med 370 2014 1422 1431
14. K.K. Ray, J.J. Kastelein, S.M. Boekholdt, and et al. The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011 Eur Heart J 35 2014 960 968
15. M. Kavousi, M.J. Leening, D. Nanchen, and et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort JAMA 311 2014 1416 1423
16. Gordon NP. Characteristics of adult health plan members in the Northern California region membership, as estimated from the 2011 member health survey. Division of Research, Kaiser Permanente Medical Care Program: Oakland, CA. 2013. Available at: https://www.dor.kaiser.org/external/mhs11reg/. Accessed March 1, 2016.
17. R.W. Yeh, S. Sidney, M. Chandra, and et al. Population trends in the incidence and outcomes of acute myocardial infarction N Engl J Med 362 2010 2155 2165
18. A.S. Go, E.M. Hylek, Y. Chang, and et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 290 2003 2685 2692
19. J.V. Selby, G.T. Ray, D. Zhang, and et al. Excess costs of medical care for patients with diabetes in a managed care population Diabetes Care 20 1997 1396 1402
20. A.J. Karter, D. Schillinger, A.S. Adams, and et al. Elevated rates of diabetes in Pacific Islanders and Asian subgroups: the Diabetes Study of Northern California (DISTANCE) Diabetes Care 36 2013 574 579
21. A.S. Go, G.M. Chertow, D. Fan, and et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
22. Miniño AM, Klein RJ. Health mortality from major cardiovascular diseases: United States, 2007. Health E-Stats. National Center for Health Statistics, 2010. Available at: http://www.cdc.gov/nchs/data/hestat/cardio2007/cardio2007.pdf. Accessed March 1, 2016.
23. D.H. Smith, M.L. Thorp, J.H. Gurwitz, and et al. Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study Circ Cardiovasc Qual Outcomes 6 2013 333 342
24. U.S. Census Bureau. 2010 Census Redistricting Data (Public Law 94-171) Summary File. 2011. Available at: https://www.census.gov/prod/cen2010/doc/pl94-171.pdf. Accessed March 24, 2016.
25. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
26. K.N. Karmali, D.C. Goff Jr., H. Ning, and et al. A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease J Am Coll Cardiol 64 2014 959 968
27. N.P. Amin, S.S. Martin, M.J. Blaha, and et al. Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines J Am Coll Cardiol 63 2014 2789 2794
28. H.M. Krumholz The new cholesterol and blood pressure guidelines: perspective on the path forward JAMA 311 2014 1403 1405